The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
News
Piranha-Proof Fish Scales Offer Inspiration for Better Armor
Arapaima gigas, resistant to breaking when a piranha bites. The answer could serve as inspiration for stronger, lightweight and flexible synthetic armors. ]]>
[…]
